Posted by Michael Wonder on 16 Sep 2022
PHARMAC can't progress cystic fibrosis drug Trikafta - CF New Zealand
16 September 2022 - PHARMAC is not in a position to progress funding on the life-extending cystic fibrosis drug, Trikafta, Cystic Fibrosis New Zealand has said today.
In a statement released by Cystic Fibrosis New Zealand, it said it had been told by PHARMAC Trikafta had not moved up the Options for Investment List.
